Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05065060 · ClinicalTrials.gov registry record
Parkinson Progression Marker Initiative Online (PPMI Online)
A clinical trial of Parkinson Disease, sponsored by Michael J. Fox Foundation for Parkinson's Research.
- Recruiting
- Registry status
- 500,000
- Enrollment target
- 1
- Study location
NCT05065060 is a study of Parkinson Disease that is actively recruiting participants, run by Michael J. Fox Foundation for Parkinson's Research. The registered enrollment target is 500,000 participants, above the 3,643-participant average among 297 other Parkinson Disease trials with a reported enrollment target (13625% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05065060, a study of Parkinson Disease, is actively recruiting participants, sponsored by Michael J. Fox Foundation for Parkinson's Research.
- RECRUITING
- Registry status
- 500,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Parkinson Progression Marker Initiative Online (PPMI Online) is an observational study collecting participant reported information from people with and without Parkinson's disease (PD), for the goal of better understanding risk and predictive factors for PD. PPMI Online is part of the broader Parkinson Progression Marker Initiative aimed at identifying markers of disease progression for use in clinical trials of therapies to reduce progression of PD disability.
Conditions Studied
Interventions
- OTHER Observation
Study Locations (1)
California
- UCSF Movement Disorders and Neuromodulation Center (MDNC) - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500,000 participants |
| Start Date | 2021-07-28 |
| Est. Completion | 2041-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05065060
The ClinicalTrials.gov registry entry for NCT05065060 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 3,643-participant average among 297 other Parkinson Disease trials with a reported enrollment target (13625% higher). The listed sponsor is Michael J. Fox Foundation for Parkinson's Research, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which Observation is the first listed.
NCT05065060 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05065060 about?
NCT05065060 is a clinical study titled "Parkinson Progression Marker Initiative Online (PPMI Online)". Parkinson Progression Marker Initiative Online (PPMI Online) is an observational study collecting participant reported information from people with and without Parkinson's disease (PD), for the goal of better understanding risk and predictive factors for PD. PPMI Online is part of the broader Parki...
What is the current status of trial NCT05065060?
This trial is currently recruiting. The enrollment target is 500,000 participants. The study started on 2021-07-28. Estimated completion is 2041-12.
What conditions does trial NCT05065060 study?
This clinical trial studies the following conditions: Parkinson Disease.
What interventions are being tested in trial NCT05065060?
The interventions under investigation include: Observation (OTHER).
Who is sponsoring clinical trial NCT05065060?
This trial is sponsored by Michael J. Fox Foundation for Parkinson's Research, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05065060 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
RECRUITING · NA
-
Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis
RECRUITING
-
University of Delaware Parkinson's Disease Registry
RECRUITING
-
Neocortical Microarchitecture of Executive Function
RECRUITING · NA
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.